Clinical Trials

Baystate researchers participate in national clinical trials that study potential new treatment methods and contribute to the advancement of science. Our commitment to research brings our patients options that might not otherwise be available to our community.

Is volunteering for a clinical trial right for you?

+ Show All Filters

Results 1 - 7 of 7

Nivolumab & Ipilimumab in Treating Patients With Rare Tumors (DART)

Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer
Olaparib and Cediranib Maleate in Treating Patients With Recurrent, Refractory, or Metastatic Endometrial Cancer

Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

The purpose of this study is to find side effects of talazoparib. Talazoparib may or may not shrink your cancer and it could also cause side effects.
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

To evaluate whether adjuvant therapy with crizotinib will result in improved overall survival (OS) for patients with stage IB >= 4 cm, II and IIIA, ALK-positive non-small cell lung cancer (NSCLC) following surgical resection.
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

This study evaluates whether the addition of chestwall + regional nodal XRT after mastectomy or breast + regional nodal XRT after breast conserving surgery will significantly reduce the rate of events for invasive breast cancer recurrence-free interval (IBC-RFI) in patients who present with histologically positive axillary nodes but convert to histologically negative axillary nodes following neoadjuvant chemotherapy.
Creation of Breast Research Registry

The purpose of this project is to create a research registry (a place to store large amounts of data) so we can use it for later studies regarding breast health and breast cancer.

Back to Top